Anson Group Expands Pharmaceutical & Biologics Regulatory Team

To meet the ever-changing challenges of companies experiencing increased regulatory workloads and fixed budgets, Anson is pleased to announce we are increasing our staff to expand our breadth of experience. Our pharmaceutical services group, directed by O. Reed Tarwater, Ph.D., RAC, doubled in numbers, substantially expanding the scope of:

· Regulatory Affairs

· PK/PD

· CM&C

· Toxicology

· Clinical Trial Management, and

· Medical/Technical Writing

Their familiarity with current and evolving FDA regulations, policies, and trends will help to provide effective and efficient services. These new experts average more than 25 years of industry experience. At Anson, it is important to us that our staff provides not only scientific excellence, but that they also demonstrate outstanding communication and collaborative skills, to ensure they are able to rapidly understand and integrate solutions into each client’s unique business culture.

Contact Anson for more information.